crashbandicoot4gamepass| Fu 'an Pharmaceutical: Subsidiary withdraws drug registration application
editor 2024-05-20 17:15:48 Home 30
Securities Times e Company Newscrashbandicoot4gamepassFu 'an Pharmaceutical (300194)(300194) announced on the evening of May 20 that the company's wholly-owned subsidiaries Qingyutang and Bosheng Pharmaceutical recently received the "Drug Registration Application Termination Notice" issued by the State Food and Drug Administration. for injectioncrashbandicoot4gamepassTaidirivibactam sodium is used for multiple infections such as complex abdominal infections caused by sensitive gram-negative bacteria, hospital-acquired pneumonia and ventilator-associated pneumonia. Affected by market changes and other factors, after careful research and combined with the company's R & D strategy, the company decided to voluntarily withdraw this registration application. The voluntary withdrawal and termination of the above-mentioned R & D drug registration application has no significant impact on the company's R & D work. At present, the company has a series of anti-infective drugs approved or passed consistency evaluation. The withdrawal of the above registration application is not expected to have a significant impact on the company's 2024 operating results.